期刊文献+

基于HepG2细胞脂质组学方法对黄浦江水质的综合评价

Comprehensive Evaluation of Water Quality of Huangpu River Using HepG2 Cell-based Lipidomics Approach
下载PDF
导出
摘要 环境水体中复合污染的毒性识别一直是环境科学界关注的热点。基于代谢组学的生物监测方法通过监测暴露前后生物内源性代谢物的变化,在评估复合污染导致的综合毒性效应中具有广泛的应用前景。本研究从污染物对细胞脂类代谢的影响角度出发,采用体外肝癌细胞(HepG2)暴露和脂质组分析相结合的方法,对黄浦江干流和支流共27个采样点的水质进行了综合评价。研究发现,水样对HepG2细胞的脂代谢影响程度与采样点所属河段紧密相关。黄浦江中游水样对HepG2细胞的平均脂代谢影响程度(3.40%)高于上游(1.65%)和下游(0.78%),而流经城区的支流水样对细胞的脂代谢影响(5.20%)明显高于干流水样(1.80%)。此外,在采集的水样中超过70%的样品都导致HepG2细胞内甘油三酯(TG)大量蓄积,揭示了黄浦江水体中的复合污染物可能诱导肝脏产生脂毒性损伤。本研究为环境水质监测提供新的方法,研究结果为上海市生态环境和水质安全管理部门提供重要的参考信息。 Toxicity characterization of complex environmental mixtures has become one of the main focuses of attention among environmental scientists.And biomonitoring using metabolomics-based approaches have the potential of providing valuable ecotoxicological information for complex environmental mixtures.In the current study,a cell-based lipidomics approach has been developed to assess the water quality of Huangpu River in Shanghai.The magnitude of impact on HepG2 lipidome was found to be dependent on the specific location of sampling sites a-long the river.The impact on HepG2 lipidome from the middle reaches samples(3.40%)is higher than that from upstream(1.65%)and downstream(0.78%),and the impact from tributaries that flow across the downtown area(5.20%)was significantly higher than that from the mainstream(1.80%).The exposed HepG2 cells exhibited a com-mon pattern of triglyceride(TG)accumulation,implying the hepatic lipotoxicity of complex mixtures of pollutants that are present in Huangpu River.Overall,this study demonstrated the utility of cell-based lipidomics as an effective tool for assessing the biological effects of complex pollutant mixtures.It also provided important information on wa-ter quality that could potentially aid in the management of ecological safety and water quality in Shanghai.
作者 印月 镇华君 修光利 Yin Yue;Zhen Huajun;Xiu Guangli(Shanghai Environmental Protection Key Laboratory for Environmental Standard and Risk Management of Chemical Pollutants,School of Resources&Environmental Engineering,East China University of Science&Technology,Shanghai 200237,China;State Environmental Protection Key Lab of Environmental Risk Assessment and Control on Chemical Processes,School of Re-sources&Environmental Engineering,East China University of Science and Technology,Shanghai 200237,China;Shanghai Institute of Pollution Control and Ecological Security,Shanghai 200092,China)
出处 《生态毒理学报》 CAS CSCD 北大核心 2021年第4期141-150,共10页 Asian Journal of Ecotoxicology
基金 上海市浦江人才计划资助项目(20PJ1402700) 国家自然科学基金项目(21707035)。
关键词 复合污染物 HEPG2细胞 综合毒性评价 脂质组学 黄浦江 complex environmental mixtures HepG2 cells mixture toxicity assessment lipidomics Huangpu River
  • 相关文献

参考文献3

二级参考文献131

  • 1Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM,Premkumar A, Kleiner DE, Gorden P. Leptin reverses nonalcoholicsteatohepatitis in patients with severe lipodystrophy. Hepatology2005; 41: 753-760 [PMID: 15791619 DOI: 10.1002/hep.20672].
  • 2Hübscher SG. Histological assessment of non-alcoholic fatty liverdisease. Histopathology 2006; 49: 450-465 [PMID: 17064291DOI: 10.1111/j.1365-2559.2006.02416.x].
  • 3Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, HolmqvistM, Bodemar G, Kechagias S. Long-term follow-up of patientswith NAFLD and elevated liver enzymes. Hepatology 2006; 44:865-873 [PMID: 17006923 DOI: 10.1002/hep.21327].
  • 4Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, ColloredoG, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N,Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G,Marcellin P, Powell EE, George J, Negro F. Relationship betweensteatosis, inflammation, and fibrosis in chronic hepatitis C: a metaanalysisof individual patient data. Gastroenterology 2006; 130:1636-1642 [PMID: 16697727 DOI: 10.1053/j.gastro.2006.03.014].
  • 5Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, HortonJD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepaticsteatosis in an urban population in the United States: impact ofethnicity. Hepatology 2004; 40: 1387-1395 [PMID: 15565570DOI: 10.1002/hep.20466].
  • 6Leleu H, Blachier M, Rosa I. Cost-effectiveness of sofosbuvir inthe treatment of patients with hepatitis C. J Viral Hepat 2015; 22:376-383 [PMID: 25219291 DOI: 10.1111/jvh.12311].
  • 7de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mistgradually clears. J Hepatol 2008; 48 Suppl 1: S104-S112 [PMID:18304679 DOI: 10.1016/j.jhep.2008.01.009].
  • 8Kaser S, Ebenbichler CF, Tilg H. Pharmacological and nonpharmacologicaltreatment of non-alcoholic fatty liver disease. IntJ Clin Pract 2010; 64: 968-983 [PMID: 20584230 DOI: 10.1111/j.1742-1241.2009.02327.x].
  • 9Byrne CD, Targher G. NAFLD: a multisystem disease. JHepatol 2015; 62: S47-S64 [PMID: 25920090 DOI: 10.1016/j.jhep.2014.12.012].
  • 10Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS, Klein S.Relationship between body fat mass and free fatty acid kineticsin men and women. Obesity (Silver Spring) 2009; 17: 1872-1877[PMID: 19629053 DOI: 10.1038/oby.2009.224].

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部